Berbée JF - Search Results

1

Interactions between inflammation and lipid metabolism: relevance for efficacy of anti-inflammatory drugs in the treatment of atherosclerosis.

van Diepen JA, Berbée JF, Havekes LM, Rensen PC. van Diepen JA, et al. Among authors: berbee jf. Atherosclerosis. 2013 Jun;228(2):306-15. doi: 10.1016/j.atherosclerosis.2013.02.028. Epub 2013 Mar 1. Atherosclerosis. 2013. PMID: 23518178 Review.

2

Hepatocyte-specific IKKβ expression aggravates atherosclerosis development in APOE*3-Leiden mice.

Wong MC, van Diepen JA, Hu L, Guigas B, de Boer HC, van Puijvelde GH, Kuiper J, van Zonneveld AJ, Shoelson SE, Voshol PJ, Romijn JA, Havekes LM, Tamsma JT, Rensen PC, Hiemstra PS, Berbée JF. Wong MC, et al. Among authors: berbee jf. Atherosclerosis. 2012 Feb;220(2):362-8. doi: 10.1016/j.atherosclerosis.2011.06.055. Epub 2011 Jul 12. Atherosclerosis. 2012. PMID: 21798539 Free PMC article.

3

Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE*3-Leiden.CETP mice.

Berbée JF, Wong MC, Wang Y, van der Hoorn JW, Khedoe PP, van Klinken JB, Mol IM, Hiemstra PS, Tsikas D, Romijn JA, Havekes LM, Princen HM, Rensen PC. Berbée JF, et al. J Nutr Biochem. 2013 Aug;24(8):1423-30. doi: 10.1016/j.jnutbio.2012.11.009. Epub 2013 Jan 18. J Nutr Biochem. 2013. PMID: 23337345

4

The effect of PPE-induced emphysema and chronic LPS-induced pulmonary inflammation on atherosclerosis development in APOE*3-LEIDEN mice.

Khedoe PP, Wong MC, Wagenaar GT, Plomp JJ, van Eck M, Havekes LM, Rensen PC, Hiemstra PS, Berbée JF. Khedoe PP, et al. Among authors: berbee jf. PLoS One. 2013 Nov 26;8(11):e80196. doi: 10.1371/journal.pone.0080196. eCollection 2013. PLoS One. 2013. PMID: 24303000 Free PMC article.

5

BCG lowers plasma cholesterol levels and delays atherosclerotic lesion progression in mice.

van Dam AD, Bekkering S, Crasborn M, van Beek L, van den Berg SM, Vrieling F, Joosten SA, van Harmelen V, de Winther MPJ, Lütjohann D, Lutgens E, Boon MR, Riksen NP, Rensen PCN, Berbée JFP. van Dam AD, et al. Atherosclerosis. 2016 Aug;251:6-14. doi: 10.1016/j.atherosclerosis.2016.05.031. Epub 2016 May 19. Atherosclerosis. 2016. PMID: 27232458 Free article.

6

Deuterium-reinforced polyunsaturated fatty acids protect against atherosclerosis by lowering lipid peroxidation and hypercholesterolemia.

Berbée JFP, Mol IM, Milne GL, Pollock E, Hoeke G, Lütjohann D, Monaco C, Rensen PCN, van der Ploeg LHT, Shchepinov MS. Berbée JFP, et al. Atherosclerosis. 2017 Sep;264:100-107. doi: 10.1016/j.atherosclerosis.2017.06.916. Epub 2017 Jun 21. Atherosclerosis. 2017. PMID: 28655430

7

The Effects of Selective Hematopoietic Expression of Human IL-37 on Systemic Inflammation and Atherosclerosis in LDLr-Deficient Mice.

Hoeke G, Khedoe PPSJ, van Diepen JA, Pike-Overzet K, van de Ven B, Vazirpanah N, Mol I, Hiemstra PS, Staal FJT, Stienstra R, Netea MG, Dinarello CA, Rensen PCN, Berbée JFP. Hoeke G, et al. Int J Mol Sci. 2017 Aug 9;18(8):1672. doi: 10.3390/ijms18081672. Int J Mol Sci. 2017. PMID: 28792474 Free PMC article.

8

Atorvastatin accelerates clearance of lipoprotein remnants generated by activated brown fat to further reduce hypercholesterolemia and atherosclerosis.

Hoeke G, Wang Y, van Dam AD, Mol IM, Gart E, Klop HG, van den Berg SM, Pieterman EH, Princen HMG, Groen AK, Rensen PCN, Berbée JFP, Boon MR. Hoeke G, et al. Atherosclerosis. 2017 Dec;267:116-126. doi: 10.1016/j.atherosclerosis.2017.10.030. Epub 2017 Oct 26. Atherosclerosis. 2017. PMID: 29121499

9

Hematopoietic α7 nicotinic acetylcholine receptor deficiency increases inflammation and platelet activation status, but does not aggravate atherosclerosis.

Kooijman S, Meurs I, van der Stoep M, Habets KL, Lammers B, Berbée JF, Havekes LM, van Eck M, Romijn JA, Korporaal SJ, Rensen PC. Kooijman S, et al. Among authors: berbee jf. J Thromb Haemost. 2015 Jan;13(1):126-35. doi: 10.1111/jth.12765. Epub 2014 Nov 13. J Thromb Haemost. 2015. PMID: 25345495 Free article.

10

Apolipoprotein CI levels are associated with atherosclerosis in men with the metabolic syndrome and systemic inflammation.

van der Ham RL, Dehnavi RA, van den Berg GA, Putter H, de Roos A, Berbée JF, Romijn JA, Rensen PC, Tamsma JT. van der Ham RL, et al. Among authors: berbee jf. Atherosclerosis. 2009 Apr;203(2):355-7. doi: 10.1016/j.atherosclerosis.2008.08.011. Epub 2008 Aug 22. Atherosclerosis. 2009. PMID: 18823887 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

89 results

Search Page